Print page  Contact  Frontpage
 

7TM Pharma is a biotech company focusing on discovery and development of new drugs targeting 7TM receptors. 7TM Pharma’s primary therapeutic area is metabolic diseases, including obesity, diabetes and cardiovascular diseases. According to the WHO, there are more than 400 million clinically obese people worldwide, and the number is growing rapidly. In spite of this, there are only few approved therapies for obesity with limited effect.

 

The basis for 7TM Pharma’s drug discovery is thorough and comprehensive knowledge about 7TM receptors and their structures, which the company uses in the design of new potential drugs. In recent years, the company has established a broad pipeline of research and development programs based on in-house drug discovery and development.


Recent News
7TM Pharma receives milestone payment from asthma and allergy collaboration
Press Release Wednesday, April 16, 2008
7TM Pharma enters into drug discovery collaboration with Dr. Reddy’s on selected drug targets
Press Release Monday, March 10, 2008
Positive results from two clinical Phase I studies with the drug candidate TM30339 for the treatment of obesity
Press Release Wednesday, February 27, 2008
 
Meet us
Cell-Based Assays
Munich May 19-21, 2008
BIO International Convention
San Diego 17-20 June, 2008
Drug Discovery Automation
Amsterdam 26-27 June, 2008